• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Long COVID Leaves A Trace In Blood That Could Be Targeted With Drugs

April 12, 2024 by Deborah Bloomfield

The largest study of hospitalized COVID patients carried out in the UK to date has revealed people with long COVID may have patterns of inflammation that can be picked up in a blood sample. The patterns seem to mirror the collection of symptoms that each individual experiences, and could help doctors devise more effective treatments.

Long COVID, sometimes referred to by other names like post-COVID conditions, is a term that covers a whole range of symptoms that linger after someone has recovered from an initial COVID-19 infection. There’s been some debate around how common the condition is, but many still go by the estimate that one in 10 COVID-19 cases leads to some degree of long COVID.

Advertisement

Given how many infections with SARS-CoV-2 have been recorded since the start of the pandemic, even with the development of vaccines, that’s a lot of people contending with often debilitating long-term illness. 

“With one in ten SARS-CoV-2 infections leading to long COVID and an estimated 65 million people around the world suffering from ongoing symptoms, we urgently need more research to understand this condition,” said one of the lead investigators, Professor Peter Openshaw, in a statement. “At the moment, it’s very hard to diagnose and treat.”

As such, the new study led by a team at Imperial College London assessed a group of patients who’d been hospitalized with severe COVID-19 infection at least six months prior. While any COVID infection can lead to long-term symptoms, those with the most severe initial disease are thought to be most at risk.

Of these patients, 426 were experiencing symptoms of long COVID, whereas 233 had fully recovered. The team analyzed samples of blood plasma, looking at 368 separate proteins known to be involved in immunity and inflammation.

Advertisement

Compared with the patients who had fully recovered, the long COVID patients had detectable patterns of blood markers consistent with ongoing immune system activation. These included markers of inflammation in the myeloid cells of the bone marrow, which give rise to white blood cells, as well as a cascade of interlinked proteins called the complement system. Complement is fired up whenever there is infection or tissue damage in the body, and it’s known to be associated with numerous autoimmune diseases.

“It is unusual to find evidence of ongoing complement activation several months after acute infection has resolved, suggesting that long COVID symptoms are a result of active inflammation,” explained first author Dr Felicity Liew. 

It was even possible to link certain patterns of these blood markers with different symptom groups. Long COVID has been associated with a huge range of effects on many different systems within the body, but this analysis revealed five distinct signatures: 

  • fatigue
  • cognitive impairment
  • anxiety and depression
  • cardiorespiratory
  • gastrointestinal

While people can fall into more than one group, this information could still be helpful when it comes to designing trials for more targeted treatments. The team highlights a class of drugs called IL-1 antagonists, which are currently used to treat rheumatoid arthritis, but target components of the immune system that appear to be activated in some subtypes of long COVID.

Advertisement

There are some limitations that the team address. As Dr Liew points out, “we can’t be sure that this is applicable to all types of long COVID, especially if symptoms occur after non-hospitalized infection.” 

But a key takeaway, according to Professor Openshaw, is the clear need for an even greater understanding of the intricacies of long COVID: “This work provides strong evidence that long COVID is caused by post-viral inflammation but shows layers of complexity.”

“We hope that our work opens the way to the development of specific tests and treatments for the various types of long COVID and believe that a ‘one size fits all’ approach to treatment may not work.”

The study is published in the journal Nature Immunology.

Deborah Bloomfield
Deborah Bloomfield

Related posts:

  1. Factbox-Top announcements from Apple event
  2. WTO chief says trade must do more to address ‘devastating’ vaccine inequity
  3. Internet Figures Out Which Muppets Are Predators And Which Are Prey Based On Their Eyes
  4. AI Discovers New Material That Could Slash Lithium Use In Batteries

Source Link: Long COVID Leaves A Trace In Blood That Could Be Targeted With Drugs

Filed Under: News

Primary Sidebar

  • Unethical Experiments: When Scientists Really Should Have Stopped What They Were Doing Immediately
  • The First Humans Were Hunted By Leopards And Weren’t The Apex Predators We Thought They Were
  • Earth’s Passage Through The Galaxy Might Be Written In Its Rocks
  • What Is An Einstein Cross – And Why Is The Latest One Such A Unique Find?
  • If We Found Life On Mars, What Would That Mean For The Fermi Paradox And The Great Filter?
  • The Longest Living Mammals Are Giants That Live Up To 200 Years In The Icy Arctic
  • Entirely New Virus Detected In Bat Urine, And It’s Only The 4th Of Its Kind Ever Isolated
  • The First Ever Full Asteroid History: From Its Doomed Discovery To Collecting Its Meteorites
  • World’s Oldest Pachycephalosaur Fossil Pushes Back These Dinosaurs’ Emergence By 15 Million Years
  • The Hole In The Ozone Layer Is Healing And On Track For Full Recovery In The 21st Century, Thanks To Science
  • First Sweet Potato Genome Reveals They’re Hybrids With A Puzzling Past And 6 Sets Of Chromosomes
  • Why Is The Top Of Canada So Sparsely Populated? Meet The “Canadian Shield”
  • Humans Are In The Middle Of “A Great Evolutionary Transition”, New Paper Claims
  • Why Do Some Toilets Have Two Flush Buttons?
  • 130-Year-Old Butter Additive Discovered In Danish Basement Contains Bacteria From The 1890s
  • Prehistoric Humans Made Necklaces From Marine Mollusk Fossils 20,000 Years Ago
  • Zond 5: In 1968 Two Soviet Steppe Tortoises Beat Humans To Orbiting Around The Moon
  • Why Cats Adapted This Defense Mechanism From Snakes
  • Mother Orca Seen Carrying Dead Calf Once Again On Washington Coast
  • A Busy Spider Season Is Brewing: Why This Fall Could See A Boom Of Arachnid Activity
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version